Conference Coverage: SABCS 2022

Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment.

December 13, 2022


Adam Brufsky, MD, PhD

UPMC Hillman Cancer Center

Faculty Members

Joyce A. O’Shaughnessy, MD
Texas Oncology-Baylor Charles A. Sammons Cancer Center

Mary Cianfrocca, DO, MBA
City of Hope Comprehensive Cancer Center

Priyanka Sharma, MD
University of Kansas Medical Center 

Peter Kaufman, MD
University of Vermont Cancer Center

Mark Pegram, MD
Stanford Cancer Institute

Javier Cortes, MD, PhD
Vall d’Hebron University Hospital

Guy Jerusalem, MD, PhD
Centre Hospitalier Universitaire

Giuseppe Curigliano, MD, PhD
Istituto Europeo di Oncologia

Sample Report

Start discovering the insights

View Report


  • Advancing Therapy for Metastatic HER2+ Breast Cancer
  • Other Novel Endocrine Strategies for ER+ Breast Cancer
  • ER+ Breast Cancer – Targeting CDKs
  • Targeting Triple-Negative Breast Cancer
  • Biomarkers and Tailored Therapy
  • Other Novel Therapeutic Approaches for Breast Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.